Peter Nielsen and Executive Free People Check 

( I'm Peter Nielsen)
(1 - 6 from 7
)

Google News: Bio-Path Holdings Inc.Posted on:13 Dec 11

[PharmiWeb.com (press release)] - “Grb-2 is an important protein involved in cancer cell proliferation and survival in CML and other leukemias,” said Peter Nielsen, President and Chief Executive Officer of Bio-Path Holdings. “BP is a novel treatment approach that uses
+1